Library

Autor(en) Titel Quelle Links
Sabel M, Fleischhack G, Tippelt S, Gustafsson G, Doz F, Kortmann R, Massimino M, Navajas A, von Hoff K, Rutkowski S, Warmuth-Metz M, Clifford SC, Pietsch T, Pizer B, Lannering B, SIOP-E Brain Tumour Group Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study. Journal of neuro-oncology 2016,    
Salama A, Gaedicke G Autoimmunhaemolytische Anaemien. In: Helmut Gadner, Gerhard Gaedicke, Charlotte Niemeyer (Hrsg.): Pädiatrische Hämatologie und Onkologie 2005, p.147    
Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, Klapper W, Wacker HH, Ludwig WD, Niggli F, Mann G, Gadner H, Riehm H, Schrappe M, Reiter A Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Münster Group Report. Journal of clinical oncology 2007, 25: 3915    
Salama A, Kiesewetter H, Kalus U, Movassaghi K, Meyer O Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia. Thrombosis and haemostasis 2008, 100: 762    
Sander A, Zimmermann M, Dworzak M, Fleischhack G, von Neuhoff C, Reinhardt D, Kaspers GJ, Creutzig U Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials. Leukemia 2010    
Sasco AJ, Vainio H From in utero and childhood exposure to parental smoking to childhood cancer: a possible link and the need for action. Hum Exp Toxicol 1999, 18: 192    
Satge D, Sasco A, Carlsen N, Stiller C, Rubie H, Hero B, De Bernardi B, de Kraker J, Coze C, Kogner P, Langmark F, Hakvoort-Cammel F, Beck D, von der Weid, Parkes S, Hartmann O, Lippens R, Kamps W, Sommelet D A lack of neuroblastoma in Down syndrome. Cancer Res 1998, 58: 448    
Sauerbrey A, Bielack S, Kempf-Bielack B, Zoubek A, Paulussen M, Zintl F High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma. Bone Marrow Transplant 2001, 27: 933    
Sauerwein W et al. Brachytherapy of the orbit in young children. Radiotherapy and Oncology 2012, 103 : 164    
Scheer U, Schellong G The prognostic value of measuring cell size in acute childhood leukemia (author's transl). Klin Pädiatr 1979, 191: 127    
Scheer U, Schellong G, Riehm H Verbesserte Prognose der akuten myeloischen Leukämien bei Kindern nach intensivierter Anfangstherapie. Klinische Pädiatrie 1979, 191: 210    
Schellong G, Waubke A, Langermann H, Breu H, Kuhne B, Riehm H, Ritter J Significance of clinical and intraoperative findings for the prediction of splenic involvement in children with Hodgkin's disease. Klin Pädiatr 1982, 194: 242    
Schellong G, Creutzig U, Ritter J Treatment of acute myelogenous leukemia in children. Med Oncol Tumor Pharmacother 1985, 2: 17    
Schellong G, Bramswig J, Ludwig R, Gerein V, Jobke A, Jürgens H, Kabisch H, Stollmann B, Weinel P, Gadner H, Combined treatment strategy in over 200 children with Hodgkin's disease. Klin Pädiatr 1986, 198: 137    
Schellong G, Lietzke S, Strauch S, Kuhne B, Schneider B Results of ultrasonic, computer tomography and clinical findings for the detection of abdominal involvement in Hodgkin's disease in childhood--a retrospective statistical analysis of 145 patients in the therapeutic study DAL-HD-82. Klin Pädiatr 1986, 198: 147    
Schellong G, Waubke-Landwehr A, Langermann H, Riehm H, Bramswig J, Ritter J Prediction of splenic involvement in children with Hodgkin's disease. Significance of clinical and intraoperative findings. A retrospective statistical analysis of 154 patients in the German therapy study DAL-HD- 78. Cancer 1986, 57: 2049    
Schmidt RF, Thews G (Hrsg) Physiologie des Menschen. Springer Verlag 23. Aufl. 1987    
Schellong G, Bramswig J, Schwarze E, Wannenmacher M An approach to reduce treatment and invasive staging in childhood Hodgkin's disease. Bull Cancer 1988, 75: 41    
Schellong G, Hornig I, Bramswig J, Bokkerink J, Steinhoff A, Ludwig R, Niethammer D, Reiter A, von Lengerke H, Heinecke H, Schwarze E, Pötter R, Müller R, Wannenmacher M, Significance of procarbazine in the chemotherapy of Hodgkin's disease-- a report of the Cooperative Therapy Study DAL-HD-85. Klin Pädiatr 1988, 200: 205    
Schellong G, Hornig I, Schwarze E, Wannenmacher M Risk factor adapted treatment of Hodgkin's lymphoma in childhood. Recent Results Cancer Res 1989, 117: 205    
Schell MJ, McHaney VA, Green AA, Kun LE, Hayes FA, Horowitz M, Meyer WH Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989, 7: 754    
Schellong G, Brämswig J, Hörnig-Franz I Treatment of children with Hodgkin's disease--results of the German Pediatric Oncology Group. Ann Oncol 1992, 3 Suppl 4: 73-6: 73    
Scholz R, Kabisch H, Weber B, Roser K, Delling G, Winkler K Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol 1992, 9: 125    
Schwerdtfeger R, Schmid H, Zingsem J, Beck J, Bender-Götze C, Döpfer R, Peters H, Henze G, Siegert W High-dose VP-16 and fractionated total body irradiation followed by autologous bone marrow transplantation in children with relapsed or high-risk acute lymphoblastic leukemia. Haematol Blood Transfus 1992, 34: 568    
Schmid H, Henze G, Schwerdtfeger R, Baumgarten E, Besserer A, Scheffler A, Serke S, Zingsem J, Siegert W Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia. Bone Marrow Transplant 1993, 12: 597    
Schmidt D, Wischmeyer P, Leuschner I, Sprenger E, Langenau E, von Schweinitz D, Harms D DNA analysis in hepatoblastoma by flow and image cytometry. Cancer 1993, 72: 2914    
Schneider S, Wildhardt G, Ludwig R, Royer-Pokora B Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations. Hum Genet 1993, 91: 599    
Schrappe M Acute leukemia in children. Kinderkrankenschwester 1993, 12: 106    
Schellong G, Brämswig J, Hörnig-Franz I, Schwarze E, Pötter R, Wannenmacher M Hodgkin's disease in children. Ann Oncol 1994, 5 Suppl 2: 113-5: 113    
Schellong G, Hornig-Franz I, Rath B, Ritter J, Riepenhausen M, Kabisch H, Goldschmitt-Wuttge B, Schmidt P, Niethammer D, Gaedicke G, Schwarze E, Pötter R, Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD- 87 therapy study. Klin Pädiatr 1994, 206: 253    
Schellong G, Hörnig-Franz I, Rath B, Ritter J, Riepenhausen M, Kabisch H, Goldschmitt-Wuttge B, Schmidt P, Niethammer D, Gaedicke G Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD-87 therapy study. Klin Pädiatr 1994, 206: 253    
Schmid H, Schwerdtfeger R, Henze G, Baumgarten E, Besserer A, Scheffler A, Gallardo J, Schmidt-Wolf I, Schwella N, Zingsem J, Siegert W Autologous and allogeneic bone marrow transplantation after identical high-dose chemo-radiotherapy in children with relapsed ALL. Haematol Blood Transfus 1994, 721    
Schrappe M, Reiter A, Sauter S, Ludwig W, Wormann B, Harbott J, Bender-Gotze C, Dörffel W, Dopfer R, Frey E, Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents. Klin Pädiatr 1994, 206: 208    
Schweizer P Das Rhabdomyosarkom. Kinderheilkunde 1994, 10    
Schweizer P Resectability of malignant soft tissue tumors. Retrospective analysis of patients in the CWS 86 study. Klinische Pädiatrie 1994, 206: 263    
Schwella N, Schwerdtfeger R, Konig V, Blasczyk R, Schmid H, Schmidt-Wolf I, Henze G, Siegert W Allogeneic bone marrow transplantation for recurrence of leukemia after autologous bone marrow transplantation. Transplantation 1994, 57: 1263    
Scheurlen W, Krauss J, Kühl J No preferential loss of one parental allele of chromosome 17p13. 3 in childhood medulloblastoma. Int J Cancer 1995, 63: 372    
Schoch C, Rieder H, Freund M, Hoelzer D, Riehm H, Fonatsch C Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23). Annals Hematology 1995, 70: 195    
Schellong G The balance between cure and late effects in childhood Hodgkin's lymphoma. Ann Oncol 1996, 7 Suppl 4: 67    
Schellong G Treatment of children and adolescents with Hodgkin's disease. Baillieres Clin Haematol 1996, 9: 619    
Schellong G, Riepenhausen M, Creutzig U, Ritter J, Harbott J, Mann G, Gadner H, Group for Incidence of Secondary Leukemias After Therapy of Childhood Hodgkin's Disease Without Nitrogen-Mustard. Results of the German-Austrian Study Group. Haematology and Blood Transfusion 1996, 38: 898    
Scheurlen W, Sörensen N, Roggendorf W, Kühl J Molecular analysis of medulloblastomas occurring simultaneously in monozygotic twins. Eur J Pediatr 1996, 155: 880    
Schlehofer B, Blettner M, Geletneky K, Haaf H, Kaatsch P, Michaelis J, Mueller-Lantzsch N, Niehoff D, Winkelspecht B, Wahrendorf J, Schlehofer J Sero-epidemiological analysis of the risk of virus infections for childhood leukaemia. Int J Cancer 1996, 65: 584    
Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen J, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram C, Ludwig W, Riehm H, Lampert F, Harbott J Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia 1996, 10: 957    
Schrappe M, Reiter A, Riehm H Cytoreduction and prognosis in childhood acute lymphoblastic leukemia. J Clin Oncol 1996, 14: 2403    
Schellong G, Riepenhausen M, Creutzig U, Ritter J, Harbott J, Mann G, Gadner H Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. J Clin Oncol 1997, 15: 2247    
Scheurlen W, Seranski P, Mincheva A, Kühl J, Sörensen N, Krauss J, Lichter P, Poustka A, Wilgenbus K High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11. 2 Genes Chromosomes Cancer 1997, 18: 50    
Schrappe M, Creutzig U Akue lymphoblastische (ALL) und akute myeloblastische (AML) Leukämie, in Creutzig U, Henze G (Hrsg.) Diagnostische und therapeutische Standards in der Pädiatrischen Onkologie, München, Bern, Wien, New York, W Zuckschwerdt Verlag 1997    
Schrappe M, Reiter A Maligne Non-Hodgkin-Lymohome im Kindesalter, in Schmoll H-J, Höffken, K, Possinger K, (Hrsg.) Kompendium Internistische Onkologie, Berlin, Springer 1997, 1713    
Schrappe M, Reiter A, Welte K, Ludwig W, Harbott J, Lampert F, Henze G, Riehm H Risk adapted treatment in childhood acute lymphoblastic leukemia:data from the Berlin-Frankfurt-Münster group. Haematology and Blood Transfusion 1997    
Schrappe M, Riehm H Akute lymphoblastische Leukämie im Kindesalter in Schmoll,H-J, Höffken K,Possinger K (Hrsg.): Kompendium Internistische Onkologie, Berlin, Springer 1997    
Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Royer-Pokora B Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci U S A 1997, 94: 3972    
Schweinitz D Hepatoblastom. Diagnostische und therapeutische Standards in der Pädiatrischen Onkologie 1997, 76    
Scheurlen WG, Seranski P, Mincheva A, Kühl J, Sörensen N, Krauss J, Lichter P, Poustka A, Wilgenbus KK High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11. 2. Genes, chromosomes & cancer 1997, 18: 50    
Schilling RF Spherocytosis, splenectomy, strokes, and heat attacks. Lancet 1997, 350: 1677    
Schellong G Pediatric Hodgkin's disease. Ann Oncol 1998, 9 Suppl 5:S115-S119    
Scheurlen W, Kühl J Current diagnostic and therapeutic management of CNS metastasis in childhood primitive neuroectodermal tumors and ependymomas. J Neurooncol 1998, 38: 181    
Scheurlen W, Schwabe G, Joos S, Mollenhauer J, Sörensen N, Kühl J Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol 1998, 16: 2478    
Schilling F, Berthold F, Erttmann R, Keding G, Michaelis J, Sander J, Treuner J Neuroblastom-Früherkennung. Krebsfrüherkennung im Kindesalter. Deutsches Ärzteblatt 1998, 95: 1485    
Schilling F, Spix C, Berthold F, Erttmann R, Hero B, Michaelis J, Sander J, Tafese T, Treuner J German Neuroblastoma Mass Screening Study at 12 Months of Age. Med Pediat Oncol 1998, 31: 435    
Schmandt S, Kühl J Chemotherapy as prophylaxis and treatment of meningosis in children less than 3 years of age with medulloblastoma. J Neurooncol 1998, 38: 187    
Schneider D, Göbel U Erhöhte Werte für Alpha-1-Fetoprotein und humanes Gonadotropin. Monatsschr Kinderheilkd 1998, 146: 1094    
Schneider D, Göbel U Differentialdiagnostische Bewertung erhöhter Werte für Alpa 1-Fetoprotein und humanes Choriogonadotropin im Kindesalter. Tumordiagnose und Therapie 1998, 19: 101    
Schott G, Sperling C, Schrappe M, Ratei R, Martin M, Meyer U, Riehm H, Ludwig W Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia. Br J Haematol 1998, 101: 753    
Schrappe M, Arico M, Harbott J, Biondi A, Zimmermann M, Conter V, Reiter A, Valsecchi M, Gadner H, Basso G, Bartram C, Lampert F, Riehm H, Masera G Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia. Blood 1998, 92: 2730    
Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Pluss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H Prevention of CNS recurrence in childhood ALL. Klin Pädiatr 1998, 210: 192    
Schrappe M, Reiter A, Riehm H Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia. J Neurooncol 1998, 38: 159    
Scheurlen W, Kühl J Current diagnostic and therapeutic management of CNS metastasis in childhood primitive neuroectodermal tumors and ependymomas. Journal of neuro-oncology 1998, 38(2-3): 181    
Scheurlen WG, Schwabe GC, Joos S, Mollenhauer J, Sörensen N, Kühl J Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998, 16: 2478    
Schellong G, Dörffel W Morbus Hodgkin bei Kindern und Jugendlichen. Kompendium Internistische Onkologie 1999, 1: 2257    
Schellong G, Potter R, Bramswig J, Wagner W, Prott F, Dörffel W, Körholz D, Mann G, Rath B, Reiter A, Weissbach G, Riepenhausen M, Thiemann M, Schwarze E High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease. J Clin Oncol 1999, 17: 3736    
Schmidt B, Koscielniak E, Pilz T, Treuner J Radiation therapy in juvenile aggressive fibromatosis. Klinische Pädiatrie 1999, 211: 296    
Schneider D, Göbel U Diagnostic and therapeutic pitfalls in infants with large sacrococcygeal tumors [letter; comment] [see comments]. Pediatr Hematol Oncol 1999, 16: 481    
Schneider D, Hilgenfeld E, Schwabe D, Behnisch W, Zoubek A, Wessalowski R, Göbel U Acute myelogenous leukemia after treatment for malignant germ cell tumors in children. J Clin Oncol 1999, 17: 3226    
Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 1999, 28: 631    
Schuz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J Association of childhood leukaemia with factors related to the immune system. Br J Cancer 1999, 80: 585    
Schwartz S, Heinecke A, Zimmermann M, Creutzig U, Schoch C, Harbott J, Fonatsch C, Löffler H, Buchner T, Ludwig W, Thiel E Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance. Leuk Lymphoma 1999, 34: 85    
Schweinitz D Hepatoblastom. Leitlinien Kinderheilkunde 1999    
Schweinitz D Hepatoblastom. Onkologisches Daten- und Informationssystem (H Link und H Poliwoda) ODIN 1999    
Schilling F, Berthold F, Erttmann R, Michaelis J, Spix C, Sander J, Schwarz K, Treuner J Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany. Med Pediatr Oncol 2000, 35: 701    
Schilling F, Bihl H, Jacobsson H, Ambros P, Martinsson T, Borgstrom P, Schwarz K, Ambros I, Treuner J, Kogner P Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information. Med Pediatr Oncol 2000, 35: 688    
Schneider D, Calaminus G, Reinhard H, Gutjahr P, Kremens B, Harms D, Göbel U Primary mediastinal germ cell tumors in children and adolescents. J Clin Oncol 2000, 18: 832    
Schrappe M, Camitta B, Pui C, Eden T, Gaynon P, Gustafsson G, Janka-Schaub G, Kamps W, Masera G, Sallan S, Tsuchida M, Vilmer E Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000, 14: 2193    
Schrappe M, Reiter A, Ludwig W, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy. Blood 2000, 95: 3310    
Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig W, Henze G, Gadner H, Odenwald E, Riehm H Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia 2000, 14: 2205    
Schulz S, Becker K, Braungart E, Reichmuth C, Klamt B, Becker I, Atkinson M, Gessler M, Hofler H Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours. J Pathol 2000, 191: 162    
Schuz J, Grigat J, Stormer B, Rippin G, Brinkmann K, Michaelis J Extremely low frequency magnetic fields in residences in Germany. Distribution of measurements, comparison of two methods for assessing exposure, and predictors for the occurrence of magnetic fields above background level. Radiat Environ Biophys 2000, 39: 233    
Schuz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J Risk of childhood leukemia and parental self-reported occupational exposure to chemicals, dusts, and fumes. Cancer Epidemiol Biomarkers Prev 2000, 9: 835    
Schwabe J, Francke A, Gerharz C, Willnow U, Schneider D, Nürnberger W Immature teratoma arising from an intra-abdominal testis in a 5-month-old boy. Med Pediatr Oncol 2000 Aug ;35 (2 ):140 -1 2000, 35: 140    
Schmitt HJ, Jilg W, Rasch G Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut. Epidemiologisches Bulletin 2000, 2: 9    
Schilling F, Ambros P, Bihl H, Martinsson T, Ambros I, Borgstrom P, Jacobsson H, Falkmer U, Treuner J, Kogner P Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas. Med Pediatr Oncol 2001, 36: 56    
Schneider D, Calaminus G, Göbel U Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood. Pediatr Hematol Oncol 2001, 18: 11    
Scholz I, Popp S, Granzow M, Schoell B, Holtgreve-Grez H, Takeuchi S, Schrappe M, Harbott J, Teigler-Schlegel A, Zimmermann M, Fischer C, Koeffler H, Bartram C, Jauch A Comparative genomic hybridization in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 2001, 124: 89    
Schrappe M Workshop on minimal residual disease. Leukemia 2001, 15    
Schrappe M, Creutzig U Akute lymphoblastische- (ALL) und akute myeloische (AML) Leukämie im Kindesalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie. AWMF online 2001    
Schuz J, Kaletsch U, Kaatsch P, Meinert R, Michaelis J Risk factors for pediatric tumors of the central nervous system. Med Pediatr Oncol 2001, 36: 274    
Schuz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J High-birth weight and other risk factors for Wilms tumour. Eur J Pediatr 2001, 160: 333    
Schuz J, Kaletsch U, Meinert R, Kaatsch P, Spix C, Michaelis J Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Clin Epidemiol 2001, 54: 702    
Schneider DT, Schuster AE, Fritsch MK, Calaminus G, Harms D, Göbel U, Perlman EJ Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klinische Padiatrie 2001, 213: 204    
Schiller M, Böhm M, Zeidler C, Germeshausen M, Welte K, Luger TA, Bonsmann G [Cyclic neutropenia. Detection of a mutation in the gene for neutrophil elastase (ELA2)]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2001, 52: 790    
Schilling F, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J Neuroblastoma screening at one year of age. N Engl J Med 2002, 346: 1047    
Schilling F, Spix C, Berthold F, Erttmann R, Klein G, Sander J, Treuner J Neuroblastom-Früherkennung. Onkologe 2002, 10: 1103    
Schilling F, Spix C, Berthold F, Erttmann R, Klein G, Sander J, Treuner J Modellprojekt Neuroblastom-Früherkennung - Eine Krebsfrüherkennungsstudie im Kindesalter mit unerwartetem Ausgang. Monatschr Kinderheilkd 2002, 150: 934    
Schuck A, Ahrens S, Konarzewska A, Paulussen M, Frohlich B, Konemann S, Rube C, Rube C, Dunst J, Willich N, Jürgens H Hemithorax irradiation for Ewing tumors of the chest wall. Int J Radiat Oncol Biol Phys 2002, 54: 830    
Schuck A, Rube C, Konemann S, Rube C, Ahrens S, Paulussen M, Dunst J, Jürgens H, Willich N Postoperative radiotherapy in the treatment of Ewing tumors. Strahlenther Onkol 2002, 178: 25    
Schüz J, Kaatsch P Epidemiology of pediatric tumors of the central nervous system. Expert Rev Neurotherapeutics 2002, 2: 469    
Schrappe M, Beier R, Burger B New treatment strategies in childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2002, 15: 729    
Schneider DT, Calaminus G, Wessalowski R, Pathmanathan R, Harms D, Göbel U Therapy of advanced ovarian juvenile granulosa cell tumors. Klinische Padiatrie 2002, 214: 173    
Schmidt P, Haas RJ, Göbel U, Calaminus G [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update]. Klinische Padiatrie 2002, 214: 167    
Schwabe J, Calaminus G, Vorhoff W, Engelbrecht V, Hauffa BP, Göbel U Sexual precocity and recurrent beta-human chorionic gonadotropin upsurges preceding the diagnosis of a malignant mediastinal germ-cell tumor in a 9-year-old boy. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002, 13: 975    
Schneider DT, Schuster AE, Fritsch MK, Calaminus G, Göbel U, Harms D, Lauer S, Olson T, Perlman EJ Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes, chromosomes & cancer 2002, 34: 115    
Schaeffeler E, Stanulla M, Greil J, Schrappe M, Eichelbaum M, Zanger U, Schwab M A novel TPMT missense mutation associated with TPMT deficiency in a 5-year-old boy with ALL. Leukemia 2003, 17: 1422    
Schellong G, Riepenhausen M Spätfolgen nach Hodgkinscher Krankheit. WIR 2003, 1: 18    
Schilling F, Spix C, Berthold F, Erttmann R, Klein G, Sander J, Treuner J, Michaelis J Neuroblastom-Früherkennung im Alter von einem Jahr in Deutschland. Deutsches Ärzteblatt 2003, 25: 1442    
Schiltmeyer B, Hempel G, Schwab M, Ritter C, Klingebiel T, Boos J Population pharmacokinetics of oral busulfan in children. Int J Clin Pharmacol Ther 2003, 40: 385    
Schrappe M Prognostic factors in childhood acute lymphoblastic leukemia. Indian J Pediatr 2003, 70: 817    
Schrappe M, Beier R, Burger B New treatment strategies in childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2003, 15: 729    
Schrappe M, Zimmermann M, Stanulla M, Schrauder A Stratifizierung der ALL mit Hilfe des Nachweises minimaler Resterkrankung , Rationale und klinische Rationalisierung. Monatsschrift Kinderheilkunde 2003, 2: 138    
Schuck A, Ahrens S, Paulussen M, Kuhlen M, Konemann S, Rube C, Winkelmann W, Kotz R, Dunst J, Willich N, Jürgens H Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003, 55: 168    
Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer 2003, 105: 255    
Schwab M, Westermann F, Hero B, Berthold F Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 2003, 4: 472    
Schilling FH, Spix C, Berthold F, Erttmann R, Sander J, Treuner J, Michaelis J Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany. Cancer letters 2003, 197(1-2): 19    
Schueler AO, Jurklies C, Heimann H, Wieland R, Havers W, Bornfeld N Thermochemotherapy in hereditary retinoblastoma. Br J Ophthalmol 2003, 87: 90    
Schneider DT, Jänig U, Calaminus G, Göbel U, Harms D Ovarian sex cord-stromal tumors--a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry. Virchows Archiv : an international journal of pathology 2003, 443: 549    
Schenk J, Engelmann D, Rohrschneider W, Zieger B, Semler O, Graf N, Troger J Rhabdoid tumors of the kidney in childhood. Rofo 2004, 176: 965    
Schrappe M Evolution of BFM trials for childhood ALL. Annals Hematology 2004, 83 Suppl 1:S121-S123    
Schuck A, Mattke A, Schmidt B, Kunz D, Harms D, Knietig R, Treuner J, Koscielniak E Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors. J Clin Oncol 2004, 22: 143    
Schellong G (Eds) Verhütung und Behandlung schwerer bakterieller Infektionen bei milzlosen Personen – Informationen und Empfehlungen für Ärzte und Patienten. Eigenverlag Münster 2004    
Schellong G, Riepenhausen M Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies. Klinische Padiatrie 2004, 216: 364    
Schenk JP, Waag KL, Graf N, Wunsch R, Jourdan C, Behnisch W, Troger J, Gunther P [3D-visualization by MRI for surgical planning of Wilms tumors]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2004, 176: 1447    
Schuck A, Kuhlen M, von Schorlemer L, Ahrens S, Hunold A, Konemann S, Dunst J, Winkelmann W, Jürgens H, Willich N Radiotherapy in Ewing's tumors of the vertebral column - Results and analysis of local recurrences. STRAHLENTHERAPIE UND ONKOLOGIE 180: 24-24 Suppl. 1, JUN 2004    
Schneider DT, Calaminus G, Koch S, Teske C, Schmidt P, Haas RJ, Harms D, Göbel U Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatric blood & cancer 2004, 42: 169    
Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Klinische Padiatrie 2004 Nov-Dec; 216: 356    
Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jäger G, Schuster V Viral Infections in Pediatric Cancer Patients. Klin Pädiatr 2005, 217 Suppl 1:S67    
Schumacher-Kuckelkorn R, Hero B, Ernestus K, Berthold F Lacking immunocytological GD2 expression in neuroblastoma: report of 3 cases. Pediatric blood & cancer 2005, 45: 195    
Schüz J, Blettner M, Michaelis J, Kaatsch P Ursachen von Leukämien im Kindesalter: Resümee einer Fallkontrollstudie des Deutschen Kinderkrebsregisters. Dtsch Arztebl 102: A2557-64, 2005.    
Schenk JP, Engelmann D, Zieger B, Semler O, Wuhl E, Furtwangler R, Graf N, Troger J [Radiologic differentiation of rhabdoid tumor from Wilms' tumor and mesoblastic nephroma]. Der Urologe. Ausg. A 2005, 44: 155    
Schlomm T, Gunawan B, Schulten HJ, Sander B, Thangavelu K, Graf N, Leuschner I, Ringert RH, Fuzesi L Effects of chemotherapy on the cytogenetic constitution of Wilms' tumor. Clinical cancer research 2005, 11: 4382    
Schenk JP, Schrader C, Furtwangler R, Ko HS, Leuschner I, Graf N, Troeger J [MRI-morphology and staging of congenital mesoblastic nephroma: evaluation of a collection with 20 patients]. RoFo 2005, 177: 1373    
Schenk JP, Gunther P, Schrader C, Ley S, Furtwangler R, Leuschner I, Edelhauser M, Graf N, Troger J [Childhood kidney tumors - the relevance of imaging.] Der Radiologe 2005, 45: 1112    
Scheiderbauer J, Gnekow AK, Emser A, Hildebrandt G, Bamberg M, Kortmann RD Multizentrische prospektive kooperative Studie SIOP/GPOH „Low grade glioma„ im Kindesalter von 1996: Ergebnisse nach Strahlentherapie (Deutschland). Strahlenther Onkol 2005, 181 (Sondernr 1): 39    
Schrappe M, Creutzig U Akute lymphoblastische (ALL) und akute myeloische (AML) Leukämie im Kindesalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie. AWMF online 2005    
Schmidt, RF Physiologie des Menschen. Springer Verlag 29., vollst. neu bearb. und aktualisierte Aufl., 2005    
Schuck A, Ahrens S, von Schorlemer I, Kuhlen M, Paulussen M, Hunold A, Gosheger G, Winkelmann W, Dunst J, Willich N, Jürgens H Radiotherapy in Ewing tumors of the vertebrae: treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials. International journal of radiation oncology, biology, physics 2005, 63: 1562    
Schuck A, Hamelmann V, Bramswig JH, Konemann S, Rube C, Hesselmann S, Riesenbeck D, Horst E, Bolling T, Paulussen M, Jürgens H, Willich N Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2005, 181: 534    
Schellong G, Dörffel W, Claviez A, Körholz D, Mann G, Scheel-Walter HG, Bokkerink JP, Riepenhausen M, Luders H, Potter R, Ruhl U, DAL/GPOH Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group. Journal of clinical oncology 2005, 23: 6181    
Schneider DT, Calaminus G, Harms D, Göbel U, German Maligne Keimzelltumoren Study Group Ovarian sex cord-stromal tumors in children and adolescents. The Journal of reproductive medicine 2005, 50: 439    
Schuck A, Hamelmann V, Brämswig JH, Könemann S, Rübe C, Hesselmann S, Riesenbeck D, Horst E, Bölling T, Paulussen M, Jürgens H, Willich N Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlentherapie und Onkologie 2005, 181: 534    
Schneppenheim R, Barthels M, Budde U [Inborn and acquired von Willebrand disease]. Hamostaseologie 2005, 25: 367    
Schuck A, Ranft A, Dirksen U, Dunst J, Jürgens H, Willich, N Radiotherapy in Ewing tumours: Significance of fractionation. Strahlentherapie und Onkologie 2006, 182; 67    
Schrauder A, Reiter A, Gadner H, Niethammer D, Klingebiel T, Kremens B, Peters C, Ebell W, Zimmermann M, Niggli F, Ludwig WD, Riehm H, Welte K, Schrappe M Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. Journal of clinical oncology 2006, 24: 5742    
Schmidt M, Simon T, Hero B, Eschner W, Dietlein M, Sudbrock F, Bongartz R, Berthold F, Schicha H Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004. Nuklearmedizin. Nuclear medicine 2006, 45: 145-51; quiz N39    
Schneider DT, Zahn S, Sievers S, Alemazkour K, Reifenberger G, Wiestler OD, Calaminus G, Göbel U, Perlman EJ Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006, 19: 864    
Schrappe M, Harbott J, Riehm H Akute lymphoblastische Leukämien. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag, 2006, 656-679.    
Schneppenheim R, Zieger B Physiologie und Pathophysiologie von plasmatischer Gerinnung und Fibrinolyse. In: Gadner H, Gaedicke G, Niemeyer C, et al., editors. Pädiatrische Hämatologie und Onkologie Springer Medizin Verlag Heidelberg; 2006. p 373    
Schüz J, Weihkopf T, Kaatsch P Medication use during pregnancy and the risk of childhood cancer in the offspring. European journal of pediatrics 2007, 166: 433    
Schwartz S, Borner K, Müller K, Martus P, Fischer L, Korfel A, Auton T, Thiel E Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy. Oncologist 2007, 12: 1299    
Schreiber-Gollwitzer BM, Rauscher-Lacher, H Kognitive Spätfolgen nach allogener oder autologer Stammzelltransplantation im Kindesalter. WIR - Die Zeitschrift der Deutschen Leukämie-Forschungshilfe e.V. und der Deutschen Kinderkrebsstiftung 4 / 2007    
Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Jürgens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, Gosheger G, Schneider DT, Bury C, Diallo-Danebrock R, Ottaviano L, Gabbert HE, Poremba C Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. European journal of cancer (Oxford, England : 1990) 2008, 44: 699    
Schrappe M, Creutzig U Akute lymphoblastische (ALL) und akute myeloische (AML) Leukämie im Kindesalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie. AWMF online 2008    
Schrauder A, von Stackelberg A, Schrappe M, Cornish J, Peters C, ALL-BFM Study Group, EBMT PD WP, I-BFM Study Group Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials. Bone marrow transplantation 2008, 41 Suppl 2:S71    
Schmidt M, Simon T, Hero B, Schicha H, Berthold F The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97. European journal of cancer (Oxford, England : 1990) 2008, 44: 1552    
Schrappe M Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia. Radiation protection dosimetry 2008, 132: 130    
Schneppenheim R, Budde U [Inborn and acquired von Willebrand disease]. Hamostaseologie 2008, 28: 312    
Schneppenheim R, Budde U Angeborenes und erworbenes von Willebrand-Syndrom. Hamostaseologie 2008, 28: 312    
Schüz J, Grell K, Kinsey S, Linet MS, Link MP, Mezei G, Pollock BH, Roman E, Zhang Y, McBride ML, Johansen C, Spix C, Hagihara J, Saito AM, Simpson J, Robison LL, Dockerty JD, Feychting M, Kheifets L, Frederiksen K Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study. Blood cancer journal 2012 Dec 21; 2:e98    
Schmid H, Jaeger B, Lohse J, Suttorp M Longitudinal growth retardation in a prepuberal girl with chronic myeloid leukemia on long-term treatment with imatinib. Haematologica 2009, 94: 1177    
Schwarz AK, Stanulla M, Cario G, Flohr T, Sutton R, Möricke A, Anker P, Stroun M, Welte K, Bartram CR, Schrappe M, Schrauder A Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia. Annals of hematology 2009, 88: 897    
von Schweinitz, D Tumoren der Leber, des Pankreas und des Gastrointestinaltraktes. Kinderchirurgie    
Schmitz N, Sureda A, Dini G, Claviez A, Lymphoma and Pediatric Diseases Working Parties Allogeneic transplantation for children and adolescents with Hodgkin lymphoma. Blood 2009 Nov 12; 114: 4605    
Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W, Paw BH, Hopfner KP, Holzmann K, Russo R, Esposito MR, Spano D, De Falco L, Heinrich K, Joggerst B, Rojewski MT, Perrotta S, Denecke J, Pannicke U, Delaunay J, Pepperkok R, Heimpel H Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nature genetics 2009, 41: 936    
Schrappe M, Nachman J, Hunger S, Schmiegelow K, Conter V, Masera G, Pieters R, Pui CH 'Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000)'. Leukemia 2010, 24: 253    
Schrey D, Borghorst S, Lanvers-Kaminsky C, Hempel G, Gerss J, Möricke A, Schrappe M, Boos J Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007. Pediatric blood & cancer 2010, 54: 952    
Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S The role of radiotherapy in oseosarcoma. Cancer treatment and research 2010, 152: 147    
Schneppenheim R, Frühwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Martin Subero JI, Obser T, Oyen F, Vater I, Siebert R Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. American journal of human genetics 2010, 86: 279    
Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, Bölling T, Dieckmann K, Pötter R, Heinecke A, Brämswig J, Dörffel W Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatric blood & cancer 2010, 55: 1145-52.    
Schneider DT, Brecht IB Care for rare cancers: improved care requires improved communication. Klinische Padiatrie 2010, 222: 124    
Schneider DT, Brecht I Ein Netzwerk für besonders seltene Tumoren. WIR 2010, 3/10, 18    
Schädlich D, Friebel D, Schallner J, Gehrisch S, Siegert G, Kuhlisch E, Knöfler R [Evaluation of haemostasis in children treated with valproic acid]. Hamostaseologie 2010, 30 Suppl 1:S132    
Schramm W, Krebs H Hämophilie-Patienten in Deutschland 2008/2009 Morbidität und Mortalität Hämostaseologie Supplement 2010 2010, 30: Supplementum 1: S9-S14    
Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, Bölling T, Dieckmann K, Pötter R, Heinecke A, Brämswig J, Dörffel W Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatric blood & cancer 2010, 55: 1145    
Schmid S Der Zahlen-GAU. Neue Zürcher Zeitung am Sonntag Online 20.03.2011    
Schmitz M, Breithaupt P, Scheidegger N, Cario G, Bonapace L, Meissner B, Mirkowska P, Tchinda J, Niggli FK, Stanulla M, Schrappe M, Schrauder A, Bornhauser BC, Bourquin JP Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood 2011,Epub ahead of print    
Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Grümayer R, Möricke A, Parasole R, Zimmermann M, Dworzak M, Buldini B, Reiter A, Basso G, Klingebiel T, Messina C, Ratei R, Cazzaniga G, Koehler R, Locatelli F, Schäfer BW, Aricò M, Welte K, van Dongen JJ, Gadner H, Biondi A, Conter V Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood 2011, 118: 2077    
Schüz J Exposure to extremely low-frequency magnetic fields and the risk of childhood cancer: update of the epidemiological evidence. Progress in biophysics and molecular biology 2011, 107: 339    
Schmid I, Häberle B, Albert MH, Corbacioglu S, Fröhlich B, Graf N, Kammer B, Kontny U, Leuschner I, Scheel-Walter HG, Scheurlen W, Werner S, Wiesel T, von Schweinitz D Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Pediatric blood & cancer 2011, 58: 539    
Schneppenheim R, Budde U Von Willebrand factor and ADAMTS13 balancing primary haemostasis. Hamostaseologie 2011, 31: 275    
Schmidt R, Baumann U, Botzug K, Henning C, Stoll M, Witte, T Primäre und sekundäre Immundefekte.    
Schneider DT, Brecht IB, Olson ThA, Ferrari A (Eds) Rare Tumors In Children and Adolescents. Series: Pediatric Oncology, Springer-Verlag 2012    
Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A, Conter V, Otten J, Ohara A, Versluys AB, Escherich G, Heyman M, Silverman LB, Horibe K, Mann G, Camitta BM, Harbott J, Riehm H, Richards S, Devidas M, Zimmermann M Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med 2012, 366: 1371    
von Schweinitz D Hepatoblastoma: recent developments in research and treatment. Seminars in pediatric surgery 2012, 21: 21    
Schmid I, Häberle B, Albert MH, Corbacioglu S, Fröhlich B, Graf N, Kammer B, Kontny U, Leuschner I, Scheel-Walter HG, Scheurlen W, Werner S, Wiesel T, von Schweinitz D Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Pediatric blood & cancer 2012, 58: 539    
Schenk, M Spätfolgen von Krebs im Kindesalter - Langzeit-Nachsorge muss noch besser strukturiert werden. Dtsch Med Wochenschr 2012, 137: S7-S10, Georg Thieme Verlag KG Stuttgart, New York    
Schöning, M Sinus – und Hirnvenenthrombosen. Pädiatrie (Hrsg. Speer,C P, Gaar, M), 4. Auflage 2012    
Schönberger S, Okpanyi V, Calaminus G, Heikaus S, Leuschner I, Nicholson JC, Stoecklein NH, Schneider DT, Borkhardt A EPCAM-A novel molecular target for the treatment of pediatric and adult germ cell tumors. Genes, chromosomes & cancer 2013, 52: 24    
Schrappe M, Möricke A, Reiter A, Henze G, Welte K, Gadner H, Ludwig WD, Ritter J, Harbott J, Mann G, Klingebiel T, Gruhn B, Niemeyer C, Kremens B, Niggli F, Debatin KM, Ratei R, Stanulla M, Beier R, Cario G, Schrauder A, Zimmermann M Key Treatment Questions in Childhood Acute Lymphoblastic Leukemia: Results in 5 Consecutive Trials Performed by the ALL-BFM Study Group From 1981 to 2000. Klinische Padiatrie 2013, 225(S 01):S62-S72    
Schuster S, Beck JD, Calaminus G, am Zehnhoff-Dinnesen A, Langer T Nachsorge von krebskranken Kindern, Jugendlichen und jungen Erwachsenen - Erkennen, Vermeiden und Behandeln von Spätfolgen. AWMF online 2013    
Schmidt P, Otto M, Hechler T, Metzing S, Wolfe J, Zernikow B Did increased availability of pediatric palliative care lead to improved palliative care outcomes in children with cancer? Journal of palliative medicine 2013, 16: 1034    
Schellong G, Riepenhausen M, Ehlert K, Brämswig J, Dörffel W, Schmutzler R, Rhiem K, Bick U Brustkrebs bei jungen Frauen nach Therapie eines Hodgkin-Lymphoms im Kindes- und Jugendalter: Eine Beobachtungsstudie mit bis zu 33 Jahren Follow-up. Dtsch Arztebl Int 2014, 111(1-2): 3    
Schlitt A, Jordan K, Vordermark D, Schwamborn JR, Langer T, Thomssen C Cardiotoxicity and oncological treatments. Deutsches Arzteblatt international 2014 Mar 7; 111: 161    
Schneider DT, Orbach D, Cecchetto G, Stachowicz-Stencel T, Brummel B, Brecht IB, Bisogno G, Ferrari A, Reguerre Y, Godzinski J, Calaminus G, Patte C, Göbel U Ovarian Sertoli Leydig cell tumours in children and adolescents: An analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT). European journal of cancer (Oxford, England : 1990) 2014,Epub ahead of print    
Schrappe, M Detection and management of minimal residual disease in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 5; 2014, 244-9.    
Schreiber JE, Gurney JG, Palmer SL, Bass JK, Wang M, Chen S, Zhang H, Swain M, Chapieski ML, Bonner MJ, Mabbott DJ, Knight SJ, Armstrong CL, Boyle R, Gajjar A Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma. Neuro-oncology 2014, 16: 1129    
Schütte P, Möricke A, Zimmermann M, Bleckmann K, Reismüller B, Attarbaschi A, Mann G, Bodmer N, Niggli F, Schrappe M, Stanulla M, Kratz CP Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact. Eur J Med Genet 2015, S1769-721230063-X. [Epub ahead of print]    
Schebesch KM, Mueller S, Wendl C, Brawanski A, Riemenschneider MJ, Proescholdt M Recurrence rates and functional outcome after resection of intrinsic intramedullary tumors. Clinical neurology and neurosurgery 2015, 134: 60    
Schweitzer J, Zimmermann M, Rasche M, von Neuhoff C, Creutzig U, Dworzak M, Reinhardt D, Klusmann JH Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial. Journal of the European Academy of Dermatology and Venereology : JEADV    
Schündeln MM, Hauffa PK, Bauer JJ, Temming P, Sauerwein W, Biewald E, Bornfeld N, Hauffa BP, Grasemann C Pediatric Survivors of Retinoblastoma Are at Risk for Altered Bone Metabolism After Chemotherapy Treatment Early in Life. Pediatric hematology and oncology 2015, 32: 455    
Schneider DT Sex Cord Stromal Tumors: It is Networking-or Not Working. Pediatric blood & cancer 2015, 62: 2065    
von Schweinitz D, Becker K Hepatoblastom. S1-Leitlinie 025/011 AWMF online 2016    
Schütte P, Möricke A, Zimmermann M, Bleckmann K, Reismüller B, Attarbaschi A, Mann G, Bodmer N, Niggli F, Schrappe M, Stanulla M, Kratz CP Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact. European journal of medical genetics 2016, 59: 143    
Scheer M, Dantonello T, Hallmen E, Vokuhl C, Leuschner I, Sparber-Sauer M, Kazanowska B, Niggli F, Ladenstein R, Bielack SS, Klingebiel T, Koscielniak E Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group. Pediatric blood & cancer 2016, 63: 1198    
Schmiegelow K, Attarbaschi A, Barzilai S, Escherich G, Frandsen TL, Halsey C, Hough R, Jeha S, Kato M, Liang DC, Mikkelsen TS, Möricke A, Niinimäki R, Piette C, Putti MC, Raetz E, Silverman LB, Skinner R, Tuckuviene R, van der Sluis I, Zapotocka E, Ponte di Legno toxicity working group Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. The Lancet. Oncology 2016, 17:e231    
Scheer C, Kratz C, Witt O, Creutzig U, Reinhardt D, Klusmann JH Hematologic Response to Vorinostat Treatment in Relapsed Myeloid Leukemia of Down Syndrome. Pediatric blood & cancer 2016, 63: 1677    
Schmidt M, Hero B, Simon T I-131-mIBG therapy in neuroblastoma: established role and prospective applications. Clinical and Translational Imaging 2016, Volume 4, Issue 2, 87    
Schrappe M, Möricke A, Attarbaschi A, von Stackelberg A Akute lymphoblastische Leukämie. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland, 2. vollständig überarbeitete Auflage 2018, 269    
Schneider DT, Brecht IB Das STEP-Register für seltene Tumorerkrankungen in der Pädiatrie - It's networking – or not working. WiR - die Zeitschrift der Deutschen Leukämie-Forschungshilfe e.V. und der Deutschen Kinderkrebsstiftung 3/2018    
Schrappe M, Bleckmann K, Zimmermann M, Biondi A, Möricke A, Locatelli F, Cario G, Rizzari C, Attarbaschi A, Valsecchi MG, Bartram CR, Barisone E, Niggli F, Niemeyer C, Testi AM, Mann G, Ziino O, Schäfer B, Panzer-Grümayer R, Beier R, Parasole R, Göhring G, Ludwig WD, Casale F, Schlegel PG, Basso G, Conter V Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018, 36: 244    
Schuster AJ, Kager L, Reichardt P, Baumhoer D, Csóka M, Hecker-Nolting S, Lang S, Lorenzen S, Mayer-Steinacker R, von Kalle T, Kevric M, Werner M, Windhager R, Wirth T, Bielack SS High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients. Sarcoma 2018, 2018, 1632978    
Scholz-Kreisel P, Kaatsch P, Spix C, Schmidberger H, Marron M, Grabow D, Becker C, Blettner M Second Malignancies Following Childhood Cancer Treatment in Germany From 1980 to 2014. Deutsches Arzteblatt international 2018 Jun 8; 115: 385    
Schepke E, Tisell M, Kennedy C, Puget S, Ferroli P, Chevignard M, Doz F, Pizer B, Rutkowski S, Massimino M, Navajas A, Schwalbe E, Hicks D, Clifford SC, Pietsch T, Lannering B Effects of the growth pattern of medulloblastoma on short-term neurological impairments after surgery: results from the prospective multicenter HIT-SIOP PNET 4 study. Journal of neurosurgery. Pediatrics 2020, 1    
Schieck M, Lentes J, Thomay K, Hofmann W, Behrens YL, Hagedorn M, Ebersold J, Davenport CF, Fazio G, Moericke A, Buchmann S, Alten J, Cario G, Schrappe M, Bergmann AK, Stanulla M, Steinemann D, Schlegelberger B, Cazzaniga G, Goehring G Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia. Annals of hematology 2020, 99: 809    
Mannucci PM, Mancuso ME, Santagostino E How we choose factor VIII to treat hemophilia. Blood 2012, 119: 4108    
Scobioala S, Ranft A, Wolters H, Jabar S, Paulussen M, Timmermann B, Jürgens H, Hassenpflug W, Klingebiel T, Elsayad K, Eich HT, Dirksen U Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma. International journal of radiation oncology, biology, physics 2018 Nov 1; 102: 584    
Seeger K, Adams H, Buchwald D, Beyermann B, Kremens B, Niemeyer C, Ritter J, Schwabe D, Harms D, Schrappe M, Henze G TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group. Blood 1998, 91: 1716    
Seeger K, Buchwald D, Peter A, Taube T, Stackelberg A, Schmitt G, Henze G TEL-AML1 fusion in relapsed childhood acute lymphoblastic leukemia. Blood 1999, 94: 374    
Seeger K, Buchwald D, Taube T, Peter A, Stackelberg A, Schmitt G, Köchling J, Henze G TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Berlin-Frankfurt-Münster Study Group [letter] [see comments]. Leukemia 1999, 13: 1469    
Seeger K, Stackelberg A, Taube T, Buchwald D, Körner G, Suttorp M, Dörffel W, Tausch W, Henze G Relapse of TEL-AML1-positive acute lymphoblastic leukemia in childhood. J Clin Oncol 2001, 19: 3188    
Seeger K, Viehmann S, Buchwald D, Harbott J, Schrappe M, Stary J, Henze G, Trka J Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALL. Leukemia 2001, 15: 280    
Seeringer A, Bartelheim K, Kerl K, Hasselblatt M, Leuschner I, Rutkowski S, Timmermann B, Kortmann RD, Koscielniak E, Schneppenheim R, Warmuth-Metz M, Gerß J, Siebert R, Graf N, Boos J, Frühwald MC Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registry. Klinische Padiatrie 2014, 226: 143    
Seidemann K, Meyer U, Jansen P, Yakisan E, Rieske K, Führer M, Kremens B, Schrappe M, Reiter A Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials. Klin Pädiatr 1998, 210: 279    
Seidemann K, Tiemann M, Henze G, Sauerbrey A, Muller S, Reiter A Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency. Med Pediatr Oncol 1999, 33: 536    
Seitz R, Dodt, J Virus Safety of Prothrombin Complex Concentrates and Factor IX Concentrates. Thromb Res 1999, Suppl 1, 95: S19-S23.    
Seidemann K, Henze G, Beck J, Sauerbrey A, Kühl J, Mann G, Reiter A Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS). Ann Oncol 2000, 11 Suppl 1: 141    
Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, Dörffel W, Zimmermann M, Mann G, Gadner H, Parwaresch R, Riehm H, Reiter A Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 2001, 97: 3699    
Seidemann K, Tiemann M, Lauterbach I, Mann G, Simonitsch I, Stankewitz K, Schrappe M, Zimmermann M, Niemeyer C, Parwaresch R, Riehm H, Reiter A Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients. J Clin Oncol 2003, 21: 1782    
Seidemann K, Zimmermann M, Book M, Meyer U, Burkhardt B, Welte K, Reiter A, Stanulla M Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95. J Clin Oncol 2005, 23: 8414    
Seidel MG, Fritsch G, Matthes-Martin S, Lawitschka A, Lion T, Pötschger U, Rosenmayr A, Fischer G, Gadner H, Peters C In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation. Haematologica 2005, 90: 1405    
Seifert G, Jesse P, Laengler A, Reindl T, Lüth M, Lobitz S, Henze G, Prokop A, Lode HN Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro. Cancer letters 2008, 264: 218    
Seifert G, Kanitz JL, Pretzer K, Henze G, Witt K, Reulecke S, Voss A Improvement of Heart Rate Variability by Eurythmy Therapy After a 6-Week Eurythmy Therapy Training. Integr Cancer Ther 2011, [Epub ahead of print]    
Seifert G, Rutkowski S, Jesse P, Madeleyn R, Reif M, Henze G, Längler A 2. Anthroposophic Supportive Treatment in Children With Medulloblastoma Receiving First-line Therapy. J Pediatr Hematol Oncol 2011, Epub ahead of print    
Seitz G, Dantonello TM, Int-Veen C, Blumenstock G, Godzinski J, Klingebiel T, Schuck A, Leuschner I, Koscielniak E, Fuchs J, on behalf of the CWS-96 Study Group Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma trial CWS-96. Pediatr Blood Cancer 2011, 56: 718    
Seifert G, Rutkowski S, Jesse P, Madeleyn R, Reif M, Henze G, Längler A Anthroposophic supportive treatment in children with medulloblastoma receiving first-line therapy. Journal of pediatric hematology/oncology 2011, 33:e105    
Seidel MG, Urban C, Sipurzynski J, Beham-Schmid C, Lackner H, Benesch M High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia. British journal of haematology 2014, E-pub ahead of print    
Seitz G, Dantonello TM, Kosztyla D, Klingebiel T, Leuschner I, Fuchs J, Koscielniak E, Cooperative Soft Tissue Sarcoma Study Group Impact of Hemiscrotectomy on Outcome of Patients with Embryonal Paratesticular Rhabdomyosarcoma: Results from the Cooperative Soft Tissue Sarcoma Group Studies CWS-86, 91, 96 and 2002P. The Journal of urology 2014, Epub ahead of print    
Seitz G, Fuchs J, Sparber-Sauer M, Leuschner I, Godzinski J, Klingebiel T, Schuck A, Martus P, Dantonello TM, Koscielniak E Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial. Annals of surgical oncology 2016,    
Seidel C, von Bueren AO, Bojko S, Hoffmann M, Pietsch T, Gielen GH, Warmuth-Metz M, Bison B, Kortmann RD, Kramm CM Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients. Strahlentherapie und Onkologie 2018, 194: 215    
Selle B, Bar C, Hecker S, Schmidt-Rohr U, Viehmann S, Debatin K, Reinhardt D ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL). Leukemia 2002, 16: 1393    
Selo N, Bölling T, Ernst I, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N Acute toxicity profile of radiotherapy in 690 children and adolescents: RiSK data. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010, 97: 119    
Selt F, Hohloch J, Hielscher T, Sahm F, Capper D, Korshunov A, Usta D, Brabetz S, Ridinger J, Ecker J, Oehme I, Gronych J, Marquardt V, Pauck D, Bächli H, Stiles CD, von Deimling A, Remke M, Schuhmann MU, Pfister SM, Brummer T, Jones DT, Witt O, Milde T Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing. Oncotarget 2017 Feb 14; 8: 11460    
Seuser A, Wallny T, Oldenburg J (Hrsg) Hämophilie und Schmerz. Weller Verlag 2008    
Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Delattre O Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 1999, 8: 2359    
Seyger M, Ritterbach J, Creutzig U, Gnekow A, Göbel U, Graf N, Reiter A, Lampert F, Harbott J 12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemia. Cancer Genet Cytogenet 1995, 80: 23    
Seyyedi S, Parlowsky T, Bucsky P Interimsanalyse der interdisziplinären multizentrischen Therapieoptimierungsstudie im Kindes- und Jugendalter, GPOH-MET 97. Monatsschr. Kinderheilk 2002, 150: 1303-1304.    
Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1994, 330: 597    
Shalapour S, Eckert C, Seeger K, Pfau M, Prada J, Henze G, Blankenstein T, Kammertoens T Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia. Journal of molecular medicine 2010, 88: 249    
Shalapour S, Hof J, Kirschner-Schwabe R, Bastian L, Eckert C, Prada J, Henze G, von Stackelberg A, Seeger K High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse. Haematologica 2011, 96: 1627    
Shen JJ, Williams BJ, Zipursky A, Doyle J, Sherman SL, Jacobs PA, Shugar AL, Soukup SW, Hassold TJ Cytogenetic and molecular studies of Down syndrome individuals with leukemia. Am J Hum Genet 1995, 56: 915    
Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood 2016, 128: 2561    
Shimizu Y, Schull WJ, Kato H Cancer risk among atomic bomb survivors: the RERF Life Span Study. Radiation Effects Research Foundation. JAMA 1990, 264: 601    
Shi L, Eichelbauer D, Borchard F, Jürgens H, Göbel U, Schneider E Specificity and function of monoclonal antibodies directed against Ewing sarcoma cells. Cancer Immunol Immunother 1994, 38: 208    
Shields CL, Shields JA, Baez K, Cater JR, De Potter P Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994, 73: 692    
Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 1997, 104: 2101    
Shields JA Importance of early diagnosis of retinoblastoma. The British journal of ophthalmology 1999, 83: 1315    
Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ Chemoreduction for unilateral retinoblastoma. Archives of ophthalmology 2002, 120: 1653    
Shields CL, Shields JA Basic understanding of current classification and management of retinoblastoma. Current opinion in ophthalmology 2006, 17: 228    
Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006, 113: 2276    
Shields CL, Shields JA Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Current opinion in ophthalmology 2010, 21: 203    
Shields CL, Shields JA Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clinical & experimental ophthalmology 2010, 38: 638    
Shimamura A, Alter BP Pathophysiology and management of inherited bone marrow failure syndromes. Blood reviews 2010, 24: 101    
Shu XO, Stewart P, Wen WQ, Han D, Potter JD, Buckley JD, Heineman E, Robison LL Parental occupational exposure to hydrocarbons and risk of acute lymphocytic leukemia in offspring. Cancer Epidemiol Biomarkers Prev 1999, 8: 783    
Siemer S, Lehmann J, Reinhard H, Graf N, Loffler G, Hendrik H, Remberger K, Stockle M Prenatal diagnosis of congenital mesoblastic nephroma associated with renal hypertension in a premature child. International journal of urology : official journal of the Japanese Urological Association 2004, 11: 50    
Siepermann M, Koscielniak E, Dantonello T, Klee D, Boos J, Krefeld B, Borkhardt A, Hoehn T, Asea A, Wessalowski R Oral low-dose chemotherapy: Successful treatment of an alveolar rhabdomyosarcoma during pregnancy. Pediatr Blood Cancer 2011, [Epub ahead of print]    
Siepermann M, Koscielniak E, Dantonello T, Klee D, Boos J, Krefeld B, Borkhardt A, Hoehn T, Asea A, Wessalowski R Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy. Pediatric blood & cancer 2012, 58: 104    
Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE, Mertens AC, Whitton JA, Robison LL, Boice JD Jr Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Jan 20; 30: 239    
Silies H, Blaschke G, Hohenlochter B, Rossi R, Jürgens H, Boos J Excretion kinetics of ifosfamide side-chain metabolites in children on continuous and short-term infusion. Int J Clin Pharmacol Ther 1998, 36: 246    
Silva Junior GB, Vieira AP, Couto Bem AX, Alves MP, Meneses GC, Martins AM, Araújo SM, Libório AV, Daher EF Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent. International journal of clinical pharmacy 2014, 36: 766    
Silva Junior GB, Vieira AP, Couto Bem AX, Alves MP, Meneses GC, Martins AM, Sanches TR, Andrade LC, Seguro AC, Libório AB, Daher EF Renal Tubular Dysfunction in Sickle Cell Disease. Kidney & blood pressure research 2014, 38: 1    
Simone J, Aur R, Hustu HO, Pinkel D "Total therapy” studies of acute lymphocytic leukemia in children. Current results and prospects for cure. Cancer 1972 30: 1488    
Simon T, Hero B, Berthold F Testicular and paratesticular involvement by metastatic neuroblastoma. Cancer 2000, 88: 2636    
Simon A, Fleischhack G, Marklein G, Ritter J Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients. Klin Pädiatr 2001, 213 Suppl 1:A22-A37    
Simon T, Voth E, Berthold F Asymmetric salivary gland 123I-meta-iodobenzylguanidine uptake in a patient with cervical neuroblastoma and Horner syndrome. Med Pediat Oncol 2001, 36: 489    
Simon A, Fleischhack G Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology patients. Klin Pädiatr 2001, 213 Suppl 1:A9-A21    
Simon T, Hero B, Dupuis W, Selle B, Berthold F The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Pädiatr 2002, 214: 149    
Simon A Evidenzbasierte Empfehlungen zur Anwendung dauerhafter, zentralvenöser intravaskulärer Zugänge in der pädiatrischen Onkologie. mhp-Verlag Wiesbaden 2002    
Simon T, Hero B, Berthold F Diagnostik und Therapie des Neuroblastoms. Kinder- und Jugendmedizin 2003, 1: 31    
Simon T, Hero B, Hunneman DH, Berthold F Tumour markers are poor predictors for relapse or progression in neuroblastoma. European journal of cancer (Oxford, England : 1990) 2003, 39: 1899    
Simon T, Spitz R, Faldum A, Hero B, Berthold F New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status. Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2004, 26: 791    
Simon T, Hero B, Faldum A, Handgretinger R, Schrappe M, Niethammer D, Berthold F Consolidation treatment with chimeric anti-GD2-antibody ch14. 18 in children older than 1 year with metastatic neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004, 22: 3549    
Simon A, Beutel K, Marklein G, Fleischhack G Bacterial infections in pediatric cancer patients. Klin Pädiatr 2005, 217 Suppl 1:S17    
Simon T, Hero B, Faldum A, Handgretinger R, Schrappe M, Niethammer D, Berthold F Infants with stage 4 neuroblastoma: the impact of the chimeric anti-GD2-antibody ch14. 18 consolidation therapy. Klinische Padiatrie 2005, 217: 147    
Simon T, Hero B, Bongartz R, Schmidt M, Müller RP, Berthold F Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease. Strahlentherapie und Onkologie 2006, 182: 389    
Simon T, Längler A, Berthold F, Klingebiel T, Hero B Topotecan and etoposide in the treatment of relapsed high-risk neuroblastoma: results of a phase 2 trial. Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2007, 29: 101    
Simon T, Längler A, Harnischmacher U, Frühwald MC, Jorch N, Claviez A, Berthold F, Hero B Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial. Journal of cancer research and clinical oncology 2007, 133: 653    
Simon T, Berthold F, Borkhardt A, Kremens B, De Carolis B, Hero B Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials. Pediatr Blood Cancer 2011, 56: 578    
Simon T, Hero B, Faldum A, Handgretinger R, Schrappe M, Klingebiel T, Berthold F Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14. 18 or oral metronomic chemotherapy. BMC Cancer 2011, 18; 11: 21.    
Simon T, Niemann CA, Hero B, Henze G, Suttorp M, Schilling FH, Berthold F Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastoma. Developmental medicine and child neurology 2012, 54: 347    
Simon T, Häberle B, Hero B, von Schweinitz D, Berthold F Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013, 31: 752    
Simon T, Hero B, Schulte JH, Deubzer H, Hundsdoerfer P, von Schweinitz D, Fuchs J, Schmidt M, Prasad V, Krug B, Timmermann B, Leuschner I, Fischer M, Langer T, Astrahantseff K, Berthold F, Lode H, Eggert A 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors. Klinische Padiatrie 2017, 229: 147    
Simon T Leitlinie: Neuroblastom. S1-Leitlinie 025-008 (Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie) AWMF-online 2019    
K Singh V, Werner S, Hackstein H, Lennerz V, Reiter A, Wölfel T, Damm-Welk C, Woessmann W Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma. Clinical and experimental immunology 2016, 186: 96    
Singh AK, McGuirk JP CAR T cells: continuation in a revolution of immunotherapy. The Lancet. Oncology 2020, 21:e168-e178    
Sirin S, de Jong MC, de Graaf P, Brisse HJ, Galluzzi P, Maeder P, Bornfeld N, Biewald E, Metz KA, Temming P, Castelijns JA, Goericke SL, European Retinoblastoma Imaging Collaboration High-Resolution Magnetic Resonance Imaging Can Reliably Detect Orbital Tumor Recurrence after Enucleation in Children with Retinoblastoma. Ophthalmology 2016, 123: 635    
Skolin I, Axelsson K, Ghannad P, Hernell O, Wahlin YB Nutrient intake and weight development in children during chemotherapy for malignant disease. Oral Oncol 1997, 33 : 364    
Skokowa J, Germeshausen M, Zeidler C, Welte K Severe congenital neutropenia: inheritance and pathophysiology. Current opinion in hematology 2007, 14: 22    
Skokowa J, Lan D, Thakur BK, Wang F, Gupta K, Cario G, Brechlin AM, Schambach A, Hinrichsen L, Meyer G, Gaestel M, Stanulla M, Tong Q, Welte K NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nature medicine 2009, 15: 151    
Skokowa J, Klimiankou M, Klimenkova O, Lan D, Gupta K, Hussein K, Carrizosa E, Kusnetsova I, Li Z, Sustmann C, Ganser A, Zeidler C, Kreipe HH, Burkhardt J, Grosschedl R, Welte K Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis. Nature medicine 2012, 18: 1550    
Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, Unalan M, Kandabarau S, Makaryan V, Beekman R, Behrens K, Stocking C, Obenauer J, Schnittger S, Kohlmann A, Valkhof MG, Hoogenboezem R, Göhring G, Reinhardt D, Schlegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Zwaan CM, Touw IP, van den Heuvel-Eibrink MM, Dale DC, Welte K Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood 2014, 123: 2229    
Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K Severe congenital neutropenias. Nature reviews. Disease primers 2017, 3: 17032    
Slavc I, Urban C, Ritter J, Ambros P, Haas O, Köller U, Kurz R Paraparesis secondary to a spinal mass as the presenting feature of erythroleukaemia in a 10-month-old child. Eur J Pediatr 1992, 151: 332    
Slatter MA, Boztug H, Pötschger U, Sykora KW, Lankester A, Yaniv I, Sedlacek P, Glogova E, Veys P, Gennery AR, Peters C Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases. Bone Marrow Transplant 2015, 50: 1536    
Sluga M, Windhager R, Lang S, Heinzl H, Bielack S, Kotz R Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma. Clin Orthop 1999, 120    
van der Sluis IM, Vrooman LM, Pieters R, Baruchel A, Escherich G, Goulden N, Mondelaers V, Sanchez de Toledo J, Rizzari C, Silverman LB, Whitlock JA Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation. Haematologica 2016, 101: 279    
Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. European journal of cancer (Oxford, England : 1990) 2019, 109: 36    
Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O'Leary M, Smith FO, Reaman GH Outcomes for children and adolescents with cancer: challenges for the twenty-first century. Journal of clinical oncology 2010, 28: 2625    
Smith-Whitley, Kim, Thompson, Alexis A Indications and complications of transfusions in sickle cell disease. Pediatric blood & cancer 2012, 59, 358    
Smoots DW, Geyer JR, Lieberman DM, Berger MS Predicting disease progression in childhood cerebellar astrocytoma. Childs Nerv Syst 1998, 14: 636    
Sobota A, Sabharwal V, Fonebi G, Steinberg M How we prevent and manage infection in sickle cell disease. British journal of haematology 2015, 170: 757    
Söntgerath R, Freier S, Wulftange M, Eckert K Qualitätsmerkmale und Verbreitungsgrad behandlungsbegleitender Sporttherapie bei pädiatrisch-onkologischen Erkrankungen in Deutschland. Klinische Pädiatrie 2017, 229: 126    
Söntgerath R, Küpper L, Wulftange M, Schepper F, Christiansen H Bewegungsförderung in der Pädiatrischen Onkologie – Strukturelle Voraussetzungen und Finanzierungsmöglichkeiten anhand des Leipziger Bewegungskonzepts. Klinische Pädiatrie 2019, 231 : 150    
Soling A, Schurr P, Berthold F Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma. Anticancer Res 1999, 19: 2205    
Sommet J, Missud F, Holvoet L, Ithier G, Lorrot M, Benkerrou M, Faye A Morbidity among child travellers with sickle-cell disease visiting tropical areas: an observational study in a French tertiary care centre. Archives of disease in childhood 2013, epub ahead of print    
Sonnemann J, Eckervogt V, Truckenbrod B, Boos J, Winkelmann W, van Valen F The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro. Anticancer Drugs 2003, 14: 767    
Sowithayasakul P, Boekhoff S, Bison B, Müller HL Pregnancies after childhood craniopharyngioma - Results of KRANIOPHARYNGEOM 2000/2007 and review of the literature. Neuroendocrinology 2020, Epup ahead of print    
Sperling C, Büchner T, Creutzig U, Ritter J, Harbott J, Fonatsch C, Sauerland C, Mielcarek M, Löffler H, Ludwig W Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML. Leukemia and Lymphoma 1995, 17: 417    
Spentzouris G, Scriven RJ, Lee TK, Labropoulos N Pediatric venous thromboembolism in relation to adults. Journal of vascular surgery 2012, 55: 1785    
Spix C, Aareleid T, Stiller C, Magnani C, Kaatsch P, Michaelis J Survival of children with neuroblastoma. time trends and regional differences in Europe, 1978--1992. Eur J Cancer 2001, 37: 722    
Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes Cancer 2002, 34: 299    
Spitz R, Hero B, Ernestus K, Berthold F FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma. Med Pediatr Oncol 2003, 41: 30    
Spitz R, Hero B, Ernestus K, Berthold F Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma. Clin Cancer Res 2003, 9: 52    
Spix C, Michaelis J, Berthold F, Erttmann R, Sander J, Schilling F Lead-time and overdiagnosis estimation in neuroblastoma screening. Stat Med 2003, 22: 2877    
Spix C, Schüz J, Klein G, Kaatsch P Epidemiologie solider Tumoren im Kindes- und Jugendalter. Kinder- und Jugendmedizin 2003, 4    
Spitz R, Hero B, Ernestus K, Berthold F Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2003, 9: 4835    
Spitz R, Hero B, Skowron M, Ernestus K, Berthold F MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. European journal of cancer (Oxford, England : 1990) 2004, 40: 2753    
Spitz R, Hero B, Simon T, Berthold F Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma. Clinical cancer research 2006, 12(11 Pt 1): 3368    
Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K, Oestreich J, Fischer M, Simon T, Berthold F Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome. Genes, chromosomes & cancer 2006, 45: 1130    
Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma. Cancer genetics and cytogenetics 2006, 167: 51    
Spix C, Schmiedel S, Kaatsch P, Schulze-Rath R, Blettner M Case-control study on childhood cancer in the vicinity of nuclear power plants in Germany 1980-2003. European journal of cancer (Oxford, England : 1990) 2008, 44: 275    
Spix C, Spallek J, Kaatsch P, Razum O, Zeeb H Cancer survival among children of Turkish descent in Germany 1980-2005: a registry-based analysis. BMC cancer 2008, 8: 355    
Spix C, Schulze-Rath R, Kaatsch P, Blettner M Case-control study on risk factors for leukaemia and brain tumours in children under 5 years in Germany. Klinische Padiatrie 2009, 221: 362    
Spix C, Mergenthaler A, Kaatsch P [Data exchange between the German Childhood Cancer Registry and the Epidemiological Cancer State Registries]. Klinische Padiatrie 2009, 221: 398    
Spix C, Kaatsch P, Blettner M The German and the French studies on childhood leukemia and nuclear power: differences and similarities. International journal of cancer 2012, [Epub ahead of print]    
Spix C Fertility in survivors of childhood cancer. Deutsches Arzteblatt international 2012, 109: 124    
Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 1989, 7: 165    
Spycher BD, Feller M, Zwahlen M, Röösli M, von der Weid NX, Hengartner H, Egger M, Kuehni CE Childhood cancer and nuclear power plants in Switzerland: A census based cohort study. Int J Epidemiol 2011 Jul 12. [Epub ahead of print]    
Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, Sundstrom C, Lennert K, van Unnik JA, Mioduszewska O, et al. Updated Kiel classification for lymphomas. Lancet 1988, 1: 292    
Stahnke K, Ritter J, Schellong G, Beck J, Kabisch H, Lampert F, Creutzig U Rezidivbehandlung bei akuter myeloischer Leukämie im Kindesalter. Eine retrospektive Analyse der in der Studie AML-BFM- 83 aufgetretenen Rezidive. Klinische Pädiatrie 1992, 204: 253    
Stahnke K, Creutzig U, Ritter J, Group for Second remission in relapsed childhood acute myelogenous leukemia after pretreatment with the AML-BFM-83 protocol. Haematology and Blood Transfusion 1993, 36: 500    
Stahnke K, Ritter J, Boos J, Creutzig U Mitoxantrone-etoposide or HD-Ara-C/mitoxantrone for remission induction in children with first relapse of AML. Haematology and Blood Transfusion 1996,V: 200    
Stahnke K, Boos J, Bender-Götze C, Ritter J, Zimmermann M, Creutzig U Duration of first remission predicts remission rates and longterm survival in children with relapsed acute myelogenous leukemia. Leukemia 1998, 12: 1543    
Stanulla M, Loning L, Welte K, Schrappe M Secondary brain tumours in children with ALL. Lancet 1999, 354: 1126    
Stanulla M, Kasper B, Schrappe M, Viehmann S, Harbott J, Ludwig W, Welte K Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life. Leukemia 2000, 14: 337    
Stanulla M, Schrappe M, Brechlin A, Zimmermann M, Welte K Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia. Blood 2000, 95: 1222    
Stanulla M, Stumm M, Dieckvoss B, Seidemann K, Schemmel V, Müller-Brechlin A, Schrappe M, Welte K, Reiter A No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence. Br J Haematol 2000, 109: 117    
Stanulla M, Schrauder A, Welte K, Schrappe M Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia. BMC Blood Disord 2001, 1    
Stam R, Den Boer M, Meijerink J, Ebus M, Peters G, Noordhuis P, Janka-Schaub G, Armstrong S, Korsmeyer S, Pieters R Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. Blood 2003, 101: 1270    
Stams W, Den Boer M, Beverloo H, Meijerink J, Stigter R, van Wering E, Janka-Schaub G, Slater R, Pieters R Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. Blood 2003, 101: 2743    
Stam R, MM van, Den Boer M, Ebus M, Janka-Schaub G, Allen J, Pieters R Multidrug resistance genes in infant acute lymphoblastic leukemia. Leukemia 2004, 18: 78    
Stams WA, den Boer ML, Holleman A, Appel IM, Beverloo HB, van Wering ER, Janka-Schaub GE, Evans WE, Pieters R Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. Blood 2005, 105: 4223    
Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. Clinical cancer research 2005, 11: 2974    
Stanulla M, Seidemann K, Schnakenberg E, Book M, Mehles A, Welte K, Schrappe M, Reiter A Methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and risk of pediatric non-Hodgkin lymphoma in a German study population. Blood 2005, 105: 906    
Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M, Welte K, Ludwig WD, Bartram CR, Zanger UM, Eichelbaum M, Schrappe M, Schwab M Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 2005, 293: 1485    
von Stackelberg A, Henze G Rezidive der akuten lymphoblastischen Leukämie. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag Springer Verlag, 2006, 680    
Stanulla M, Cario G, Meissner B, Schrauder A, Möricke A, Riehm H, Schrappe M Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group. Blood cells, molecules & diseases 2007, 39: 160    
Staege MS, Banning-Eichenseer U, Weissflog G, Volkmer I, Burdach S, Richter G, Mauz-Körholz C, Föll J, Körholz D Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs. Experimental hematology 2008, 36: 886    
von Stackelberg A, Hartmann R, Bührer C, Fengler R, Janka-Schaub G, Reiter A, Mann G, Schmiegelow K, Ratei R, Klingebiel T, Ritter J, Henze G, ALL-REZ BFM Study Group High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia. Blood 2008, 111: 2573    
Stanulla M, Schaeffeler E, Möricke A, Coulthard SA, Cario G, Schrauder A, Kaatsch P, Dördelmann M, Welte K, Zimmermann M, Reiter A, Eichelbaum M, Riehm H, Schrappe M, Schwab M Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols. Blood 2009, 114: 1314    
Stanulla M, Schrappe M Treatment of childhood acute lymphoblastic leukemia. Seminars in hematology 2009, 46: 52    
Staege MS, Körholz D New treatment strategies for Hodgkin's lymphoma. Leukemia research 2009, 33: 886    
von Stackelberg A, Völzke E, Kühl JS, Seeger K, Schrauder A, Escherich G, Henze G, Tallen G, for the ALL-REZ BFM Study Group Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group. European journal of cancer 2011, 47: 90    
Stahl M, Ranft A, Paulussen M, Bölling T, Vieth V, Bielack S, Görtitz I, Braun-Munzinger G, Hardes J, Jürgens H, Dirksen U 19. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Pediatr Blood Cancer 2011,Epub ahead of print    
Stanulla M, Bourquin JP Behandlung der akuten lymphoblastischen Leukämie im Kindesalter. Pharm unserer Zeit 2012, 3    
Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S, Gonzalez A, Izraeli S, Janic D, Jazbec J, Konja J, Kaiserova E, Kowalczyk J, Kovacs G, Li CK, Magyarosy E, Popa A, Stark B, Jabali Y, Trka J, Hrusak O, Riehm H, Masera G, Schrappe M Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. Journal of clinical oncology 2014, 32: 174    
Stankov MV, El Khatib M, Kumar Thakur B, Heitmann K, Panayotova-Dimitrova D, Schoening J, Bourquin JP, Schweitzer N, Leverkus M, Welte K, Reinhardt D, Li Z, Orkin SH, Behrens GM, Klusmann JH Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia 2014, 28: 577    
Stapleton JL, Tatum KL, Devine KA, Stephens S, Masterson M, Baig A, Hudson SV, Coups EJ Skin Cancer Surveillance Behaviors Among Childhood Cancer Survivors. Pediatric blood & cancer 2016, 63: 554    
Stadt UZ, Escherich G, Indenbirken D, Alawi M, Adao M, Horstmann MA Rapid Capture Next-Generation Sequencing in Clinical Diagnostics of Kinase Pathway Aberrations in B-Cell Precursor ALL. Pediatric blood & cancer 2016, 63: 1283    
Stanulla M, Dagdan E, Zaliova M, Moericke A, Palmi C, Cazzaniga G, Eckert C, Te Kronnie G, Bourquin JP, Bornhauser B, Koehler R, Bartram CR, Ludwig WD, Bleckmann K, Groeneveld-Krentz S, Schewe D, Junk SV, Hinze L, Klein N, Kratz CP, Biondi A, Borkhardt A, Kulozik A, Muckenthaler MU, Basso G, Valsecchi MG, Izraeli S, Petersen BS, Franke A, Dörge P, Steinemann D, Haas OA, Panzer-Grümayer R, Cavé H, Houlston RS, Cario G, Schrappe M, Zimmermann M, TRANSCALL Consortium,International BFM Study Group IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Journal of clinical oncology 2018, 36: 1240    
Stanulla M, Kratz C Genetische Prädispositionen für Krebserkrankungen, in Niemeyer CH, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie 2018, 2. Aufl.: 169    
Zur Stadt U, Alawi M, Adao M, Indenbirken D, Escherich G, Horstmann MA Characterization of novel, recurrent genomic rearrangements as sensitive MRD targets in childhood B-cell precursor ALL. Blood cancer journal 2019, 9: 96    
Steinberg S, Hartmann R, Wisniewski S, Berger K, Beck J, Henze G Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood. Klin Pädiatr 1998, 210: 200    
Steiner M, Burkart W, Grosche B, Kaletsch U, Michaelis J Trends in infant leukaemia in West Germany in relation to in utero exposure due to Chernobyl accident. Radiat Environ Biophys 1998, 37: 87    
Steinbach D, Dörffel W, Eggers G, Holfeld E, Kluba U, Krause I, Lauterbach I, Reiss T, Rieske K, Scharfe V, Schumacher R, Weigel H, Weinmann G, Zintl F, Hermann J Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87. Klin Pädiatr 2001, 213: 162    
Steinbach D, Hermann J, Littlewood T, Zintl F Risk group definition in children with acute myeloid leukemia by calculating individual risk factors on the basis of a multivariate stepwise Cox regression analysis. Leuk Lymphoma 2001, 42: 1289    
Steliarova-Foucher E, Berrino F, Coebergh J, Kaatsch P, Lacour B, Michaelis J, Mitlon N, Stiller C, Parkin D ACCISpass 1. 01, software for analysis and presentation of data on incidence and survival of children and adolescents in Europe. European Network of Cancer Registries 2002    
Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh J, Lacour B, Parkin M Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since 1970s. Lancet 2004    
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P International Classification of Childhood Cancer, third edition. Cancer 2005, 103: 1457    
Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, ACCIS Scientific Committee Trends in childhood cancer incidence in Europe, 1970-99. Lancet 2005, 365: 2088    
Steffens J, Treiyer A, Calaminus G [Management of pediatric testicular tumors : diagnosis, therapy, and follow-up]. Der Urologe. Ausg. A 2009, 48: 359    
Stegmaier S, Poremba C, Schaefer KL, Leuschner I, Kazanowska B, Békássy AN, Bielack SS, Klingebiel T, Koscielniak E Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma study group (CWS). Pediatr Blood Cancer 2011, 57: 406    
Steinbach D, Wilhelm B, Kiermaier HR, Creutzig U, Schrappe M, Zimmermann M, Debatin KM, Gruhn B, von Stackelberg A, Jürgens H, Strahm B, Reinhardt D, Möricke A 35. Long term survival in children with acute leukaemia and complications requiring mechanical ventilation. Arch Dis Child 2011, [Epub ahead of print]    
Steinlin M A clinical approach to arterial ischemic childhood stroke: increasing knowledge over the last decade. Neuropediatrics 2012, 43: 1    
Steinbach D, Bader P, Willasch A, Bartholomae S, Debatin KM, Zimmermann M, Creutzig U, Reinhardt D, Gruhn B Prospective validation of a new method of monitoring minimal residual disease in childhood acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2014, epub ahead of print    
Sterkenburg AS, Hoffmann A, Reichel J, Lohle K, Eveslage M, Warmuth-Metz M, Mueller HL Nuchal Skinfold Thickness: A Novel Parameter for Assessment of Body Composition in Childhood Craniopharyngioma. The Journal of clinical endocrinology and metabolism 2016, 101: 4922    
Streetly A, Sisodia R, Dick M, Latinovic R, Hounsell K, Dormandy E Evaluation of newborn sickle cell screening programme in England: 2010-2016. Archives of disease in childhood 2017    
Stiller CA, Nectoux J International incidence of childhood brain and spinal tumours. Int J Epidemiol 1994, 23: 458    
Stöhr M, Brandt T, Einhäupl KM (Hrsg) Neurologische Syndrome in der Intensivmedizin. Differentialdiagnose und Akuttherapie. Kohlhammer Verlag 1190    
Stohr W, Langer T, Kremers A, Brecht I, Treuner J, Dinnesen A, Beck J Hearing function in soft tissue sarcoma patients after treatment with carboplatin. Oncology Reports 2004, 12: 767    
Stohr W, Langer T, Kremers A, Bielack S, Lamprecht-Dinnesen A, Frey E, Beck JD, German Late Effects Working Group in the German Society of Pediatric Oncology and Hematology Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance system. Cancer investigation 2005, 23: 201    
Stohr W, Paulides M, Brecht I, Kremers A, Treuner J, Langer T, Beck JD Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS). Journal of cancer research and clinical oncology 2006, 132: 35    
Stöhr W, Paulides M, Bielack S, Jürgens H, Treuner J, Rossi R, Langer T, Beck JD Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatric blood & cancer 2007, 48: 447    
Stöhr W, Paulides M, Bielack S, Jürgens H, Koscielniak E, Rossi R, Langer T, Beck JD Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system. Pediatric blood & cancer 2007, 48: 140    
Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-oncology 2010, 12: 1257    
Stoepker C, Hain K, Schuster B, Hilhorst-Hofstee Y, Rooimans MA, Steltenpool J, Oostra AB, Eirich K, Korthof ET, Nieuwint AW, Jaspers NG, Bettecken T, Joenje H, Schindler D, Rouse J, de Winter JP SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet 2011, 43: 138    
Stock A, Mynarek M, Pietsch T, Pfister SM, Clifford SC, Goschzik T, Sturm D, Schwalbe EC, Hicks D, Rutkowski S, Bison B, Pham M, Warmuth-Metz M Imaging Characteristics of Wingless Pathway Subgroup Medulloblastomas: Results from the German HIT/SIOP-Trial Cohort. AJNR 2019, 40: 1811    
Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol 2001, 19: 2696    
Sträter R, Becker S, von Eckardstein A, Heinecke A, Gutsche S, Junker R, Kurnik K, Schobess R, Nowak-Göttl U Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study. Lancet 2002 Nov 16; 360: 1540    
Streif W, Knöfler R, Eberl W Inherited disorders of platelet function in pediatric clinical practice: a diagnostic challenge. Klinische Padiatrie 2010, 222: 203    
Strahm B, Nöllke P, Zecca M, Korthof ET, Bierings M, Furlan I, Sedlacek P, Chybicka A, Schmugge M, Bordon V, Peters C, O'Marcaigh A, de Heredia CD, Bergstraesser E, Moerloose BD, van den Heuvel-Eibrink MM, Starý J, Trebo M, Wojcik D, Niemeyer CM, Locatelli F, EWOG-MDS study group Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia 2011, 25: 455    
Strahm B, Nöllke P, Zecca M, Korthof ET, Bierings M, Furlan I, Sedlacek P, Chybicka A, Schmugge M, Bordon V, Peters C, O'Marcaigh A, de Heredia CD, Bergstraesser E, Moerloose BD, van den Heuvel-Eibrink MM, Starý J, Trebo M, Wojcik D, Niemeyer CM, Locatelli F, EWOG-MDS study group Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia 2011, 25: 455    
Strouse JJ, Heeney MM Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children. Pediatric blood & cancer 2012, 59: 365    
Streif W, Knöfler R, Eberl W, Andres O, Bakchoul T, Bergmann F, Beutel K, Dittmer R, Gehrisch S, Gottstein S, Halimeh S, Haselböck J, Hassenpflug WA, Heine S, Holzhauer S, King S, Kirchmaier CM, Krause M, Kreuz W, Lösche W, Mahnel R, Maurer M, Nimtz-Talaska A, Olivieri M, Rott H, Schambeck ChM, Schedel A, Schilling FH, Schmugge M, Schneppenheim R, Scholz U, Scholz T, Schulze H, Siegemund A, Strauß G, Sykora KW, Wermes C, Wiegering V, Wieland I, Zieger B, Zotz RB, Paediatric Committee of the Society of Thrombosis and Haemostasis Research [Therapy of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)]. Hamostaseologie 2014, 34: 269-75, quiz 276    
Streif W, Knöfler R S2k-Leitlinie: Diagnose von Thrombozytenfunktionsstörungen - Thrombozytopathien. AWMF-Registernummer 086-003 Stand Februar 2018    
Streif W, Knöfler R, Meyer O S2k-Leitlinie: Therapie angeborener thrombozytärer Erkrankungen. AWMF-Registernummer 086-004 Stand April 2020    
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352: 987    
Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Kleijn I, Dee R, Hooft L, van Noesel MM, Bierings M, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma. Journal of clinical oncology 2008, 26: 5443    
Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Yalcin B, Dee R, van Noesel MM, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers. Clinical chemistry 2009, 55: 1316    
Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, Liu XY, Fontebasso AM, Ryzhova M, Albrecht S, Jacob K, Wolter M, Ebinger M, Schuhmann MU, van Meter T, Frühwald MC, Hauch H, Pekrun A, Radlwimmer B, Niehues T, von Komorowski G, Dürken M, Kulozik AE, Madden J, Donson A, Foreman NK, Drissi R, Fouladi M, Scheurlen W, von Deimling A, Monoranu C, Roggendorf W, Herold-Mende C, Unterberg A, Kramm CM, Felsberg J, Hartmann C, Wiestler B, Wick W, Milde T, Witt O, Lindroth AM, Schwartzentruber J, Faury D, Fleming A, Zakrzewska M, Liberski PP, Zakrzewski K, Hauser P, Garami M, Klekner A, Bognar L, Morrissy S, Cavalli F, Taylor MD, van Sluis P, Koster J, Versteeg R, Volckmann R, Mikkelsen T, Aldape K, Reifenberger G, Collins VP, Majewski J, Korshunov A, Lichter P, Plass C, Jabado N, Pfister SM Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer cell 2012, 22: 425    
Stöhr W, Langer T, Kremers A, Bielack S, Dinnesen A, Frey E, Beck J Cisplatin-induced Ototoxicity in Osteosarcoma Patients. Cancer Investigation 2004,in press    
Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d'Enghien C, Brousse N, Jais JP, Fischer A, Hermine O, Stoppa-Lyonnet D Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Jan 10; 33: 202    
Subbiah V, Ketonen L, Bruner JM, Nunez R, Weinberg J, Wolff JE 99mTc-sestamibi scan differentiates tumor from other contrast enhancing tissue in choroid plexus tumors. J Clin Onco 2010, 32: 160    
Sudbrock F, Schmidt M, Simon T, Eschner W, Berthold F, Schicha H Dosimetry for (131)I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma. European journal of nuclear medicine and molecular imaging 2010,    
Surico G, Muggeo P, Rigillo N, Gadner H Concurrent Langerhans cell histiocytosis and myelodysplasia in children. Med Pediatr Oncol 2000, 35: 421    
Sutor A, Niemeyer C, Sauter S, Witt I, Kaufmehl K, Rombach A, Brandis M, Riehm H Changes in blood coagulation in treatment with ALL-BFM-90 and NHL-BFM-90 protocols. Klin Pädiatr 1992, 204: 264    
Sutton LN, Molloy PT, Sernyak H, Goldwein J, Phillips PL, Rorke LB, Moshang T Jr, Lange B, Packer RJ Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 1995, 83: 583    
Sutor AH Abklärung einer Blutungsneigung. Hämostaseologie 2010, 20: 1    
Sutor AH Thrombocytosis in children. Semin Thromb Hemost 1995; 21(3): 330-339 1995, 21: 330    
Suttorp M, Millot F Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation. Hematology 2010, 368    
Suttorp M, Yaniv I, Schultz KR Controversies in the treatment of CML in children and adolescents: TKIs versus BMT? Biology of blood and marrow transplantation 2011, 17(1 Suppl):S115    
Suttorp M, Eckardt L, Tauer JT, Millot F Management of chronic myeloid leukemia in childhood. Current hematologic malignancy reports 2012, 7: 116    
Suttorp M, Schulze P, Glauche I, Gaehring G, von Neuhoff N, Metzler M, Sedlacek P, de Bont ESJM, Balduzzi A, Lausen B, Aleinikova O, Sufliarska S, Henze G, Strauss G, Eggert A, Kremens B, Groll AH, Berthold F, Klein C, Groß-Wieltsch U, Sykora KW, Borkhardt A, Kulozik AE, Schrappe M, Nowasz C, Krumbholz M, Tauer JT, Claviez A, Harbott J, Kreipe HH, Schlegelberger B, Thiede C Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. Leukemia 2018, ePup ahead of print    
Suttorp M, Bornhäuser M, Metzler M, Millot F, Schleyer E Pharmacology and pharmacokinetics of imatinib in pediatric patients. Expert review of clinical pharmacology 2018, 11: 219    
Suttorp M Chronische myeloische Leukämie, in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland, 2. vollständig überarbeitete Auflage 2018, 303    
Suttorp M, Metzler M, Millot F, Shimada H, Bansal D, Guenes AM, Kalwak K, Sedlacek P, Baruchel A, Biondi A, Hijiya N, Schultz KR, Schrappe M Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients. Pediatric blood & cancer 2018, 65:e27431    
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Eds) WHO Classification of Tumours of the Haematopoetic and Lymphoid Tissues. Lyon, France: IARC Press 2008, 109    
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2017, revised 4th edition    
Sykora K, Tomeczkowski J, Kirchhoff K, Yakisan E, Reiter A, Welte K Growth inhibition of IL-7 receptor positiv childhood Burkitt's lymphoma cells is due to induction of apoptosis. Molecular Biology of Hematopoiesis 1996, 191    
Sykora K, Tomeczkowski J, Reiter A C-kit receptors in childhood malignant lymphoblastic cells. Leuk Lymphoma 1997, 25: 201    
Szavay P, Luithle T, Semler O, Graf N, Fuchs J Surgery of cavoatrial tumor thrombus in nephroblastoma. Pediatr Blood Cancer 2004, 43: 40    
Szavay P, Fuchs J, Leuschner I, Selle B, Graf N Nierentumoren, in: Fuchs J (Hrsg.): Solide Tumoren im Kindesalter, Grundlagen – Diagnostik – Therapie. Schauttauer GmbH 2012, 111    
Szczepański T, van der Velden VHJ, Waanders E, Kuiper RP, Van Vlierberghe P, Gruhn B, Eckert C, Panzer-Grümayer R, Basso G, Cavé H, zur Stadt U, Campana D, Schrauder A, Sutton R, van Wering E, Meijerink JPP, van Dongen JJM Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition. Journal of Clinical Oncology 2011, 1643    
439 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.